bromocriptine has been researched along with Kidney Diseases in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (50.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, HY; Lin, SJ; Wu, ZB; Zhao, WG | 1 |
| Graziano, G; Jannini, EA; Johnson, DW; Lucisano, G; Navaneethan, SD; Querques, M; Ruospo, M; Saglimbene, V; Strippoli, GF; Vecchio, M | 1 |
| Cambon, C; Hussain, T; Kunduzova, O; Lokhandwala, M; Narkar, V; Parini, A | 1 |
| Misra, P | 1 |
| Chiarini, C; De March, A; Degli Esposti, E; Flamigni, C; Fuschini, G; Santoro, A; Sturani, A; Zuccalà, A; Zucchelli, P | 1 |
| Luginbühl, H; Richardson, B | 1 |
| Adnoral, SA; Daminov, MA; Ermolenko, VM; Kukhtevich, AV; Obydena, EA; Shakhbazian, IE; Smirnova, GA; Sushkova, NI | 1 |
| Bunatian, AF; Ermolenko, VM; Gitel', EP; Kukhtevich, AV; Smirnova, GA | 1 |
2 review(s) available for bromocriptine and Kidney Diseases
| Article | Year |
|---|---|
Cabergoline versus bromocriptine for the treatment of giant prolactinomas: A quantitative and systematic review.
Topics: Adult; Bromocriptine; Cabergoline; Female; Humans; Hydranencephaly; Kidney Diseases; Male; Middle Aged; Prolactin; Prolactinoma; Sex Distribution; Treatment Outcome | 2018 |
Interventions for treating sexual dysfunction in patients with chronic kidney disease.
Topics: Bromocriptine; Chlorides; Chronic Disease; Erectile Dysfunction; Female; Humans; Kidney Diseases; Male; Phosphodiesterase 5 Inhibitors; Randomized Controlled Trials as Topic; Renal Dialysis; Sexual Dysfunction, Physiological; Testosterone; Vitamin D; Vitamin E; Vitamins; Zinc; Zinc Compounds | 2010 |
6 other study(ies) available for bromocriptine and Kidney Diseases
| Article | Year |
|---|---|
Dopamine D2-like receptor agonist bromocriptine protects against ischemia/reperfusion injury in rat kidney.
Topics: Animals; Apoptosis; Bromocriptine; Dopamine Agonists; Kidney Cortex; Kidney Diseases; Male; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Necrosis; Phosphorylation; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Reperfusion Injury; Sodium-Potassium-Exchanging ATPase | 2004 |
Hepatic encephalopathy.
Topics: Amino Acids; Ammonia; Bromocriptine; Constipation; Dietary Proteins; Gastrointestinal Hemorrhage; Hepatic Encephalopathy; Humans; Hypnotics and Sedatives; Infections; Kidney Diseases; Lactulose; Levodopa; Liver Diseases; Neomycin; Neurotransmitter Agents | 1981 |
Dopaminergic control of sympathetic activity and blood pressure in haemodialysis patients.
Topics: Adult; Bromocriptine; Humans; Hypertension; Kidney Diseases; Male; Middle Aged; Norepinephrine; Prolactin; Receptors, Dopamine; Renal Dialysis; Sympathetic Nervous System | 1983 |
The role of prolactin in the development of chronic progressive nephropathy in the rat.
Topics: Aging; Animals; Bromocriptine; Kidney; Kidney Diseases; Male; Prolactin; Rats | 1976 |
[Use of zinc and parlodel for treatment of physical and sexual development retardation in kidney diseases and rheumatoid arthritis].
Topics: Adolescent; Arthritis, Rheumatoid; Body Height; Body Weight; Bromocriptine; Child; Developmental Disabilities; Humans; Immunosuppressive Agents; Kidney Diseases; Risk Factors; Zinc | 1991 |
[Zinc and parlodel: the treatment potentials for retardation of growth and sexual development in nephropathies in adolescents].
Topics: Adolescent; Body Height; Body Weight; Bromocriptine; Child; Disorders of Sex Development; Drug Evaluation; Growth Disorders; Hormones; Humans; Kidney Diseases; Male; Sexual Maturation; Sperm Count; Zinc | 1989 |